- Home
- ALUR vs SLGL Comparison
ALUR vs SLGL Comparison
Compare ALUR & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- SLGL
- Stock Information
- Founded
- ALUR 2009
- SLGL 1997
- Country
- ALUR United States
- SLGL Israel
- Employees
- ALUR N/A
- SLGL N/A
- Industry
- ALUR
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- ALUR
- SLGL Health Care
- Exchange
- ALUR Nasdaq
- SLGL Nasdaq
- Market Cap
- ALUR 22.8M
- SLGL 21.1M
- IPO Year
- ALUR N/A
- SLGL 2018
- Fundamental
- Price
- ALUR $2.69
- SLGL $7.24
- Analyst Decision
- ALUR Strong Buy
- SLGL Buy
- Analyst Count
- ALUR 3
- SLGL 1
- Target Price
- ALUR $22.83
- SLGL $40.00
- AVG Volume (30 Days)
- ALUR 857.0K
- SLGL 13.2K
- Earning Date
- ALUR 05-14-2025
- SLGL 05-23-2025
- Dividend Yield
- ALUR N/A
- SLGL N/A
- EPS Growth
- ALUR N/A
- SLGL N/A
- EPS
- ALUR N/A
- SLGL N/A
- Revenue
- ALUR $28,304,000.00
- SLGL $12,103,000.00
- Revenue This Year
- ALUR N/A
- SLGL N/A
- Revenue Next Year
- ALUR $49.35
- SLGL $31.17
- P/E Ratio
- ALUR N/A
- SLGL N/A
- Revenue Growth
- ALUR N/A
- SLGL 603.66
- 52 Week Low
- ALUR $2.15
- SLGL $3.34
- 52 Week High
- ALUR $88.75
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- ALUR 49.19
- SLGL 50.26
- Support Level
- ALUR $2.35
- SLGL $7.15
- Resistance Level
- ALUR $3.00
- SLGL $7.45
- Average True Range (ATR)
- ALUR 0.26
- SLGL 0.32
- MACD
- ALUR -0.01
- SLGL -0.10
- Stochastic Oscillator
- ALUR 37.36
- SLGL 31.36
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.